Hussman Strategic Advisors’s Phibro Animal Health PAHC Stock Holding History

Hussman Strategic Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Hold	42,000	–	–	0.3%	155
2026 Q1	$2.32M	Hold	42,000	–	–	0.5%	79
2025 Q4	$1.57M	Hold	42,000	–	–	0.38%	119
2025 Q3	$1.7M	Sell	42,000 -42,000	-50%	-$1.39M	0.37%	127
2025 Q2	$2.15M	Sell	84,000 -42,000	-33%	-$916K	0.49%	82
2025 Q1	$2.69M	Buy	126,000 +21,000	+20%	+$469K	0.65%	41
2024 Q4	$2.21M	Buy	+105,000	New	+$2.43M	0.65%	48
2023 Q2	–	Sell	-26,000	Closed	-$398K	–	332
2023 Q1	$398K	Hold	26,000	–	–	0.06%	285
2022 Q4	$349K	Hold	26,000	–	–	0.06%	272
2022 Q3	$346K	Hold	26,000	–	–	0.06%	266
2022 Q2	$497K	Hold	26,000	–	–	0.09%	266
2022 Q1	$519K	Hold	26,000	–	–	0.1%	254
2021 Q4	$531K	Buy	+26,000	New	+$555K	0.12%	242

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Hussman Strategic Advisors's PAHC Position: Q2 2026 in Review

Hussman Strategic Advisors held its Phibro Animal Health (PAHC) position steady in Q2 2026 at 42,000 shares worth $1.32M. The position accounts for 0.3% of the portfolio, ranked #155.

Hussman Strategic Advisors first reported a position in PAHC in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.69M in Q1 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Hussman Strategic Advisors held 42,000 shares of Phibro Animal Health worth $1.32M as of Q2 2026.
Hussman Strategic Advisors left its Phibro Animal Health share count unchanged in Q2 2026.
Phibro Animal Health made up 0.3% of Hussman Strategic Advisors's portfolio in Q2 2026, its #155 holding.
Hussman Strategic Advisors first reported a position in Phibro Animal Health in Q4 2021 and has held it in 13 quarters since.
Hussman Strategic Advisors's Phibro Animal Health position peaked at $2.69M in Q1 2025.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.